Nigella sativa (Black Cumin) seed extract alleviates symptoms of allergic diarrhea in mice, involving opioid receptors

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Duncker, Swantje C ^a   Philippe, David ^a   Martin Paschoud, Christine ^a   Moser, Mireille ^a   Mercenier, Annick ^a   Nutten, Sophie ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRINASE; CHYMASE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; KAPPA OPIATE RECEPTOR AGONIST; NIGELLA SATIVA EXTRACT; OVALBUMIN; THYMOQUINONE; THYMOQUINONE KAPPA; U 50'488; U50 4889; UNCLASSIFIED DRUG;

ALLERGIC DIARRHEA; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FOOD ALLERGY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE; MALE; MAST CELL; MASTOCYTOSIS; MOUSE; NONHUMAN; PLANT SEED; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

ANIMALS; BENZOQUINONES; BIOLOGICAL MARKERS; CHYMASES; DIARRHEA; FOOD HYPERSENSITIVITY; LIGANDS; MALE; MICE; MICE, INBRED BALB C; NIGELLA SATIVA; OVALBUMIN; PHYTOTHERAPY; PLANT EXTRACTS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SEEDS;

MURINAE; MUS; NIGELLA SATIVA;

EID: 84863100077     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039841     Document Type: Article

References (58)

1. Gerez IF, Lee BW, van Bever HP, Shek LP, (2010) Allergies in Asia: differences in prevalence and management compared with western populations. Expert Rev Clin Immunol 6: 279-289.
2. Zuercher AW, Fritsche R, Corthesy B, Mercenier A, (2006) Food products and allergy development, prevention and treatment. Curr Opin Biotechnol 17: 198-203. S0958-1669(06)00024-3 [pii];10.1016/j.copbio.2006.01.010 [doi].
3. Ramesh S, (2008) Food allergy overview in children. Clin Rev Allergy Immunol 34: 217-230. 10.1007/s12016-007-8034-1 [doi].
4. Sicherer SH, Sampson HA, (2010) Food allergy. J Allergy Clin Immunol 125: S116-S125. S0091-6749(09)01270-6 [pii];10.1016/j.jaci.2009.08.028 [doi].
5. Sicherer SH, (2011) Epidemiology of food allergy. J Allergy Clin Immunol. S0091-6749(10)01868-3 [pii];10.1016/j.jaci.2010.11.044 [doi].
6. Bock SA, (1987) Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 79: 683-688.
7. Luccioli S, Ross M, Labiner-Wolfe J, Fein SB, (2008) Maternally reported food allergies and other food-related health problems in infants: characteristics and associated factors. Pediatrics 122 Suppl 2: S105-S112. 122/Supplement_2/S105 [pii];10.1542/peds.2008-1315n [doi].
8. Venter C, Pereira B, Voigt K, Grundy J, Clayton CB, Higgins B, et al. (2008) Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life. Allergy 63: 354-359. ALL1570 [pii];10.1111/j.1398-9995.2007.01570.x [doi].
9. Garcia-Careaga M Jr, Kerner JA Jr, (2005) Gastrointestinal manifestations of food allergies in pediatric patients. Nutr Clin Pract 20: 526-535. 20/5/526 [pii].
10. Prescott S, Allen KJ, (2011) Food allergy: Riding the second wave of the allergy epidemic. Pediatr Allergy Immunol 22: 155-160. 10.1111/j.1399-3038.2011.01145.x [doi].
11. Mainardi T, Kapoor S, Bielory L, (2009) Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 123: 283-294. S0091-6749(08)02439-1 [pii];10.1016/j.jaci.2008.12.023 [doi].
12. Gupta S, George P, Gupta V, Tandon VR, Sundaram KR, (1979) Tylophora indica in bronchial asthma-a double blind study. Indian J Med Res 69: 981-989.
13. Lee DK, Carstairs IJ, Haggart K, Jackson CM, Currie GP, et al. (2003) Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clin Exp Allergy 33: 882-886. 1705 [pii].
14. Schempp CM, Windeck T, Hezel S, Simon JC, (2003) Topical treatment of atopic dermatitis with St. John's wort cream-a randomized, placebo controlled, double blind half-side comparison. Phytomedicine 10: 31-37.
15. Lutterodt H, Luther M, Salvin M, Yin J-J, Perry J, Gao J-M, et al. (2011) Fatty acid profile, thymoquinone content, oxidative stability, and antioxidative properties of cold-pressed black cumin seed oils. LWT-Food Science and Technology 43: 1409-1413.
16. Ramadan MF, Morsel JT, (2002) AID-FOOD240&3.0.CO;2-1 [doi].
17. Ghosheh OA, Houdi AA, Crooks PA, (1999) High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal 19: 757-762. S0731-7085(98)00300-8 [pii].
18. Tiruppur Venkatachallam SK, Pattekhan H, Divakar S, Kadimi US, (2010) Chemical composition of Nigella sativa L. seed extracts obtained by supercritical carbon dioxide. J Food Sci Technol 47: 598-605.
19. Padhye S, Banerjee S, Ahmad A, Mohammad R, Sarkar FH, (2008) From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer Ther 6: 495-510.
20. Butt MS, Sultan MT, (2010) Nigella sativa: reduces the risk of various maladies. Crit Rev Food Sci Nutr 50: 654-665. 925289763 [pii];10.1080/10408390902768797 [doi].
21. Mansour M, Tornhamre S, (2004) Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J Enzyme Inhib Med Chem 19: 431-436. 10.1080/14756360400002072 [doi].
22. Vaillancourt F, Silva P, Shi Q, Fahmi H, Fernandes JC, et al. (2011) Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. J Cell Biochem 112: 107-117. 10.1002/jcb.22884 [doi].
23. Isik F, Tunali AT, Yarat A, Genc Z, Pisiriciler R, et al. (2011) Protective effects of black cumin (Nigella sativa) oil on TNBS-induced experimental colitis in rats. Dig Dis Sci 56: 721-730. 10.1007/s10620-010-1333-z [doi].
24. Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, et al. (2010) Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer 62: 938-946. 927591507 [pii];10.1080/01635581.2010.509832 [doi].
25. Nikakhlagh S, Rahim F, Aryani FH, Syahpoush A, Brougerdnya MG, et al. (2010) Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaryngol. S0196-0709(10)00140-7 [pii];10.1016/j.amjoto.2010.07.019 [doi].
26. Boskabady MH, Mohsenpoor N, Takaloo L, (2010) Antiasthmatic effect of Nigella sativa in airways of asthmatic patients. Phytomedicine 17: 707-713. S0944-7113(10)00018-8 [pii];10.1016/j.phymed.2010.01.002 [doi].
27. El Gazzar M, El Mezayen R, Nicolls MR, Marecki JC, Dreskin SC, (2006) Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma. Biochim Biophys Acta 1760: 1088-1095. S0304-4165(06)00072-9 [pii];10.1016/j.bbagen.2006.03.006 [doi].
28. Abdel-Fattah AM, Matsumoto K, Watanabe H, (2000) Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol 400: 89-97. S001429990000340X [pii].
29. Hosseinzadeh H, Parvardeh S, (2004) Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine 11: 56-64.
30. Hosseinzadeh H, Parvardeh S, Nassiri-Asl M, Mansouri MT, (2005) Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med Sci Monit 11: BR106-BR110. 5295 [pii].
31. Shahbazian A, Heinemann A, Schmidhammer H, Beubler E, Holzer-Petsche U, et al. (2002) Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine. Br J Pharmacol 135: 741-750. 10.1038/sj.bjp.0704527 [doi].
32. Shook JE, Lemcke PK, Gehrig CA, Hruby VJ, Burks TF, (1989) Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. J Pharmacol Exp Ther 249: 83-90.
33. Wood JD, Galligan JJ, (2004) Function of opioids in the enteric nervous system. Neurogastroenterol Motil 16 Suppl 2: 17-28. 10.1111/j.1743-3150.2004.00554.x [doi]; NMO554 [pii].
34. Rogers TJ, Peterson PK, (2003) Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 24: 116-121. S1471490603000036 [pii].
35. Brandt EB, Strait RT, Hershko D, Wang Q, Muntel EE, et al. (2003) Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 112: 1666-1677.
36. El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A, et al. (2006) Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int Immunopharmacol 6: 1135-1142. S1567-5769(06)00060-9 [pii];10.1016/j.intimp.2006.02.004 [doi].
37. Abbas AT, Abdel-Aziz MM, Zalata KR, Tel AA-G, (2005) Effect of dexamethasone and Nigella sativa on peripheral blood eosinophil count, IgG1 and IgG2a, cytokine profiles and lung inflammation in murine model of allergic asthma. Egypt J Immunol 12: 95-102.
38. Chakravarty N, (1993) Inhibition of histamine release from mast cells by nigellone. Ann Allergy 70: 237-242.
39. Kanter M, Coskun O, Uysal H, (2006) The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage. Arch Toxicol 80: 217-224. 10.1007/s00204-005-0037-1 [doi].
40. Buyukozturk S, Gelincik A, Ozseker F, Genc S, Savran FO, et al. (2005) Nigella sativa (black seed) oil does not affect the T-helper 1 and T-helper 2 type cytokine production from splenic mononuclear cells in allergen sensitized mice. J Ethnopharmacol 100: 295-298. S0378-8741(05)00214-X [pii];10.1016/j.jep.2005.03.007 [doi].
41. Badary OA, Gamal El-Din AM, (2001) Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. Cancer Detect Prev 25: 362-368.
42. Houghton PJ, Zarka R, de las Heras B, Hoult JR, (1995) Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61: 33-36. 10.1055/s-2006-957994 [doi].
43. Finlay TM, Abdulkhalek S, Gilmour A, Guzzo C, Jayanth P, et al. (2010) Thymoquinone-induced Neu4 sialidase activates NFkappaB in macrophage cells and pro-inflammatory cytokines in vivo. Glycoconj J 27: 583-600. 10.1007/s10719-010-9302-5 [doi].
44. Philippe D, Dubuquoy L, Groux H, Brun V, Chuoi-Mariot MT, et al. (2003) Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 111: 1329-1338.
45. Barbezat GO, Clain JE, Halter F, (1979) A double-blind trial of loperamide in the treatment of chronic diarrhoea. S Afr Med J 55: 502-503.
46. Jaffe G, (1977) A comparison of lomotil and imodium in acute non-specific diarrhoea. J Int Med Res 5: 195-198.
47. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J, (1989) Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97: 575-585. S0016508589002738 [pii].
48. Poonyachoti S, Brown DR, (2001) delta-opioid receptors inhibit neurogenic intestinal secretion evoked by mast cell degranulation and type I hypersensitivity. J Neuroimmunol 112: 89-96.
49. Stead RH, Colley EC, Wang B, Partosoedarso E, Lin J, et al. (2006) Vagal influences over mast cells. Auton Neurosci 125: 53-61. S1566-0702(06)00004-X [pii];10.1016/j.autneu.2006.01.002 [doi].
50. Philippe D, Dubuquoy L, Groux H, Brun V, Chuoi-Mariot MT, et al. (2003) Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 111: 1329-1338. 10.1172/JCI16750 [doi].
51. Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M, (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23: 737-746. S0896-6273(01)80032-5 [pii].
52. Sirohi S, Kumar P, Yoburn BC, (2007) Mu-opioid receptor up-regulation and functional supersensitivity are independent of antagonist efficacy. J Pharmacol Exp Ther 323: 701-707. jpet.107.127019 [pii];10.1124/jpet.107.127019 [doi].
53. Verma-Gandhu M, Verdu EF, Cohen-Lyons D, Collins SM, (2007) Lymphocyte-mediated regulation of beta-endorphin in the myenteric plexus. Am J Physiol Gastrointest Liver Physiol 292: G344-G348. 00318.2006 [pii];10.1152/ajpgi.00318.2006 [doi].
54. Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, et al. (1993) Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A 90: 9954-9958.
55. Simonin F, Befort K, Gaveriaux-Ruff C, Matthes H, Nappey V, et al. (1994) The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol Pharmacol 46: 1015-1021.
56. Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, et al. (1994) Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett 338: 217-222. 0014-5793(94)80368-4 [pii].
57. Zuercher AW, Holvoet S, Weiss M, Mercenier A, (2010) Polyphenol-enriched apple extract attenuates food allergy in mice. Clin Exp Allergy 40: 942-950. CEA3460 [pii];10.1111/j.1365-2222.2010.03460.x [doi].
58. Perrier C, Thierry AC, Mercenier A, Corthesy B, (2010) Allergen-specific antibody and cytokine responses, mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice. Clin Exp Allergy 40: 153-162. CEA3329 [pii];10.1111/j.1365-2222.2009.03329.x [doi].